USPH.NYSEU S Physical Therapy INC /NV

Form 4: U.S. Physical Therapy Executive Sells Shares

Sentiment:

SEC Form 4 Filing

📋All filings for U S Physical Therapy INC /NV
🔒Login to Follow

Richard Binstein, EVP Gen'l Counsel & Secretary at U.S. Physical Therapy, sold 1,128 shares of common stock at $98.52 per share on November 25, 2024.

Summary

  • Richard Binstein, an executive at U.S. Physical Therapy, sold 1,128 shares of the company's common stock on November 25, 2024.
  • The sale price was $98.52 per share.
  • Following the transaction, Mr. Binstein directly owns 11,767 shares.
  • This includes 10,417 shares granted as restricted stock under the company's 2003 Stock Incentive Plan.
  • The restricted stock vests over time, with portions vesting on various dates from January 1, 2025, to January 1, 2028, contingent on his continued employment.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider stock sale, which is a normal business activity. There is no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It provides transparency into the transactions of company executives.

Comparison to Industry Standards

  • Executive stock sales are a common occurrence in publicly traded companies, and this transaction is not unusual.
  • The vesting schedule for restricted stock is typical for executive compensation packages, designed to align executive interests with long-term company performance.
  • Companies like Select Medical Holdings (SEM) and Encompass Health (EHC), which are also in the healthcare services sector, often have similar insider trading activity and stock-based compensation plans.

Stakeholder Impact

  • The stock sale by an executive may have a minor impact on shareholder sentiment, but it is unlikely to be significant given the relatively small number of shares sold.
  • The vesting schedule of restricted stock ensures that the executive's interests are aligned with the long-term performance of the company.

Key Dates

DateDescription
11/25/2024Date of the stock sale transaction.
11/26/2024Date of signature on the SEC Form 4.
01/01/2025First vesting date for 1,241 restricted shares.
04/01/2025Vesting date for 1,045 restricted shares.
07/01/2025Vesting date for 1,045 restricted shares.
10/01/2025Vesting date for 1,045 restricted shares.
01/01/2026Vesting date for 1,049 restricted shares.
04/01/2026Vesting date for 740 restricted shares.
07/01/2026Vesting date for 740 restricted shares.
10/01/2026Vesting date for 740 restricted shares.
01/01/2027Vesting date for 747 restricted shares.
04/01/2027Vesting date for 506 restricted shares.
07/01/2027Vesting date for 506 restricted shares.
10/01/2027Vesting date for 506 restricted shares.
01/01/2028Final vesting date for 507 restricted shares.

Keywords

insider trading, stock sale, executive, restricted stock, USPH, U.S. Physical Therapy, Richard Binstein

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.